Literature DB >> 23380687

Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states.

Berthold Drexler1, Stefan Zinser, Shengming Huang, Michael M Poe, Uwe Rudolph, James M Cook, Bernd Antkowiak.   

Abstract

Neocortical neurons mediate the sedative and anticonvulsant properties of benzodiazepines. These agents enhance synaptic inhibition via positive modulation of γ-aminobutyric acid (GABAA) receptors harboring α1-, α2-, α3- or α5-protein subunits. Benzodiazepine-sensitive GABAA receptors containing the α5-subunit are abundant in the neocortex, but their impact in controlling neuronal firing patterns is unknown. Here we studied how the discharge rates of cortical neurons are modified by a positive (SH-053-2'F-R-CH3) and a negative (L 655,708) α5-subunit-preferring allosteric modulator in comparison to diazepam, the classical non-selective benzodiazepine. Drug actions were characterized in slice cultures from wild-type and α5(H105R) knock-in mice by performing extracellular multi-unit-recordings. In knock-in mice, receptors containing the α5 subunit are insensitive to benzodiazepines. The non-selective positive allosteric modulator diazepam decreased the discharge rates of neocortical neurons during episodes of ongoing neuronal activity (up states). In contrast to diazepam, the α5-preferring positive modulator SH-053-2'F-R-CH3 accelerated action potential firing during up states. This promoting action was absent in slices from α5(H105R) mice, confirming that it is mediated by the α5-subunit. Consistent with these observations, the negative α5-selective modulator L 655,708 inhibited up state action potential activity in slices from wild-type mice. The opposing actions of diazepam and SH-053-2'F-R-CH3, which both enhance GABAA receptor function but differ in subtype-selectivity, uncovers contrasting roles of GABAA receptor subtypes in controlling the firing rates of cortical neurons. These findings may have important implications for the design of novel anaesthetic and anticonvulsant benzodiazepines displaying an improved efficacy and fewer side effects.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380687      PMCID: PMC3996676          DOI: 10.1016/j.ejphar.2013.01.034

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  45 in total

Review 1.  A new benzodiazepine pharmacology.

Authors:  H Möhler; J M Fritschy; U Rudolph
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

2.  Maturation of neurons in neocortical slice cultures: A light and electron microscopic study on in situ and in vitro material.

Authors:  M Caeser; A Schüz
Journal:  J Hirnforsch       Date:  1992

3.  Barrages of synaptic activity control the gain and sensitivity of cortical neurons.

Authors:  Yousheng Shu; Andrea Hasenstaub; Mathilde Badoual; Thierry Bal; David A McCormick
Journal:  J Neurosci       Date:  2003-11-12       Impact factor: 6.167

Review 4.  Mechanisms underlying synapse-specific clustering of GABA(A) receptors.

Authors:  Alex M Thomson; Jasmina N Jovanovic
Journal:  Eur J Neurosci       Date:  2010-06-09       Impact factor: 3.386

5.  Neocortex is the major target of sedative concentrations of volatile anaesthetics: strong depression of firing rates and increase of GABAA receptor-mediated inhibition.

Authors:  Harald Hentschke; Cornelius Schwarz; Bernd Antkowiak
Journal:  Eur J Neurosci       Date:  2005-01       Impact factor: 3.386

6.  Diazepam decreases action potential firing of neocortical neurons via two distinct mechanisms.

Authors:  Berthold Drexler; Stefan Zinser; Harald Hentschke; Bernd Antkowiak
Journal:  Anesth Analg       Date:  2010-10-01       Impact factor: 5.108

7.  Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate.

Authors:  Victor Y Cheng; Loren J Martin; Erin M Elliott; John H Kim; Howard T J Mount; Franco A Taverna; John C Roder; John F Macdonald; Amit Bhambri; Neil Collinson; Keith A Wafford; Beverley A Orser
Journal:  J Neurosci       Date:  2006-04-05       Impact factor: 6.167

8.  Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors.

Authors:  F Crestani; R Keist; J-M Fritschy; D Benke; K Vogt; L Prut; H Blüthmann; H Möhler; U Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

9.  Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.

Authors:  Roland Baur; Kelly R Tan; Benjamin P Lüscher; Anne Gonthier; Maurice Goeldner; Erwin Sigel
Journal:  J Neurochem       Date:  2008-07-15       Impact factor: 5.372

10.  PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.

Authors:  Miroslav M Savić; Terry Clayton; Roman Furtmüller; Ivana Gavrilović; Janko Samardzić; Snezana Savić; Sigismund Huck; Werner Sieghart; James M Cook
Journal:  Brain Res       Date:  2008-02-19       Impact factor: 3.252

View more
  7 in total

1.  Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the α5 subunit.

Authors:  Tamara Timić Stamenić; Michael M Poe; Sabah Rehman; Anja Santrač; Branka Divović; Petra Scholze; Margot Ernst; James M Cook; Miroslav M Savić
Journal:  Eur J Pharmacol       Date:  2016-09-14       Impact factor: 4.432

2.  Negative modulation of α₅ GABAA receptors in rats may partially prevent memory impairment induced by MK-801, but not amphetamine- or MK-801-elicited hyperlocomotion.

Authors:  Tamara Timić Stamenić; Srdjan Joksimović; Poonam Biawat; Tamara Stanković; Bojan Marković; James M Cook; Miroslav M Savić
Journal:  J Psychopharmacol       Date:  2015-06-23       Impact factor: 4.153

3.  α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit.

Authors:  Matthew Townsend; Andrew Whyment; Jean-Sebastien Walczak; Ross Jeggo; Marco van den Top; Dorothy G Flood; Liza Leventhal; Holger Patzke; Gerhard Koenig
Journal:  J Neurophysiol       Date:  2016-09-21       Impact factor: 2.714

4.  Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects.

Authors:  Aleksandar Lj Obradović; Srđan Joksimović; Michael M Poe; Joachim Ramerstorfer; Zdravko Varagic; Ojas Namjoshi; Bojan Batinić; Tamara Radulović; Bojan Marković; Brian L Roth; Werner Sieghart; James M Cook; Miroslav M Savić
Journal:  Brain Res       Date:  2014-01-25       Impact factor: 3.252

Review 5.  GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.

Authors:  Uwe Rudolph; Hanns Möhler
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-23       Impact factor: 13.820

6.  Differential depression of neuronal network activity by midazolam and its main metabolite 1-hydroxymidazolam in cultured neocortical slices.

Authors:  Monika Balk; Harald Hentschke; Uwe Rudolph; Bernd Antkowiak; Berthold Drexler
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

7.  Zolpidem Activation of Alpha 1-Containing GABAA Receptors Selectively Inhibits High Frequency Action Potential Firing of Cortical Neurons.

Authors:  Elena Neumann; Uwe Rudolph; Daniel E Knutson; Guanguan Li; James M Cook; Harald Hentschke; Bernd Antkowiak; Berthold Drexler
Journal:  Front Pharmacol       Date:  2019-01-09       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.